Lynkcell Europe
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations (NCT05904730) | Lynkcell Europe | 2023-07-11 |
Track Lynkcell Europe automatically
Every clearance here is in the API, with alerts when new ones post.